Citation 99699

SAKAI,T: PERLMAN,D:. (1975). CHARACTERISTICS OF TWO BROAD SPECTRUM ANTIBIOTICS PRODUCED BY MYCOPLASMA SP. RP III.. 28()

Citation Details

TitleCHARACTERISTICS OF TWO BROAD SPECTRUM ANTIBIOTICS PRODUCED BY MYCOPLASMA SP. RP III.
AuthorsSAKAI,T: PERLMAN,D:
Year1975
Volume28
Issue

Summary

Year: 1975

Journal: Unknown

Organisms and Their Experiments (1)

Mycoplasma species (MYCOPLASMATACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
INACTIVE
2
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
3
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
4
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
5
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
6
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
7
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
8
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
9
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
10
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
11
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
12
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
13
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
14
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
15
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
16
ANTIYEAST ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
INACTIVE
17
ANTIYEAST ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
INACTIVE
18
CYTOTOXIC ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
STRONG ACTIVITY
19
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
20
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
21
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
22
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
23
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
24
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
25
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
26
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
27
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
28
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
29
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
30
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
31
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
32
ANTIBACTERIAL ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
33
ANTIYEAST ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
34
ANTIYEAST ACTIVITY
PMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDTLC DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MYCOPLASMA RP-III ANTIBIOTIC FACTOR II
ACTIVE
35
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
36
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MYCOPLASMA RP-III ANTIBIOTIC FACTOR I
ACTIVE
Show SPARQL Queries (1)